Search CommunityWalk:


Cylex, Inc

8980-I Old Annapolis Road
Columbia, MD 21045, USA

Category: Diagnostic/Imaging; Research Services & Supplies

Used in the following map:

Maryland Biotech Industry Map

Cylex Inc is a life science company focused on the development, manufacture and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. It was founded in 1992.

Cylex has developed patented technology that provides an innovative platform to simply and reproducibly assess immune cell function, thus providing crucial insight for individualized transplant patient management. Its ImmuKnow is a noninvasive biomarker of immune function that assesses cellular immune status by detecting cell-mediated immunity (CMI) in adult immunosuppressed patients. It measures the concentration of adenosine triphosphate (ATP) released from CD4 cells following cell stimulation. The ImmuKnow test is a qualitative assay and does not directly quantify the level of immunosuppression. The company's technology is used to help and identify kidney, liver, lung and heart transplant patients with low immune response - having the potential to lead to infection.

Cylex has alliances with Dynal Biotech, Life Technologies Corporation, and Medical & Biological Laboratories Co., Ltd. (MBL). The company's investors include: Canaan Partners, Channel Medical Partners, First Analysis and Siemens Venture Capital (SVC). It is an ISO 13485:2003 and 9001:2000 certified company.